BioArctic
Overview
BioArctic is a Swedish biopharmaceutical company specializing in the development of novel treatments for neurodegenerative diseases, with a focus on Alzheimer's disease and Parkinson's disease. The company leverages advanced neurotechnology platforms and biomarker research to discover and develop disease-modifying therapies that address the underlying pathology of neurological disorders.
More in Neurotechnology
Latest industry news
A Female PhD Pioneer Leads a Brain-Computer Interface Startup to a Landmark IPO
2026-09-08 · Industry
At-Home Neuromodulation Is Coming for Depression — and It's Closer Than You Think
2026-09-07 · Product
New Accelerator Seeks to Bring Neurotech Startups From Lab to Market Faster
2026-09-06 · Industry
China Accelerates Its Brain-Computer Interface Ambitions in a Major National Push
2026-09-05 · Industry
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →